| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.11 | 0.07 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.078 | 0.07 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.073 | 0.07 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.07 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.08 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.08 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.08 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.07 | 0.08 |